Newsroom
Newsroom
Blog Posts
Earlier this month, my cofounder Kristy Hawkins and I presented at SynBioBeta 2020, the flagship conference for the synthetic biology community. This year’s virtual event...
Blog Posts
As a part of our new “Meet the Team” series, we hear from Ken Takeoka, Antheia’s very first employee and a Scientist III. Read on...
Blog Posts
It’s a momentous day for my research team at Stanford University. Today, we’ve announced a new paper published in Nature that describes the first successful...
Blog Posts
Over the last 150 years, the pharmaceutical industry has focused on decoupling the production of medicinal compounds from their sources in the natural world, which...
Blog Posts
We started Antheia four years ago with a steadfast commitment to help build a more robust drug supply chain – one that delivers the right...
Blog Posts
mericans spend over $300 billion on pharmaceutical drugs every year. In normal times, the supply chain behind these drugs is designed to go unnoticed......
Blog Posts
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply chain to produce...
Blog Posts
Fermentation is one of humanity’s oldest and most pivotal technological developments. Through fermentation, societies began adapting their diets nearly ten millennia ago, to include new...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank,...
Blog Posts
Synthetic biology is often touted as a software-driven and automation-empowered approach to biological research. Buzzwords like artificial intelligence and robotics are commonly used alongside the...
Blog Posts
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people experience the...
Industry News
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support of lead researcher Shugeng Cao,...
Industry News
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes......
Industry News
The intricacies of the pharmaceutical supply chain may not have been in the mainstream news a few years ago, but recent events kicked this subject...
Industry News
Yeast plays an important role in food and beverage production, but its properties also make it an excellent factory for many compounds, including medication......
Industry News
Researchers report the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of neuromuscular blockers naturally found in plants in the...
Industry News
When Covid hit and hospitals started reporting shortages of hydroxychloroquine and other medicines vital to patients with conditions like malaria, lupus, asthma, and COPD, it...
Industry News
Successful production of medicinal compounds from plants depends on weather and growing seasons, potentially making supply chains vulnerable to uncontrollable forces. One way around such...
Blog Posts
Earlier this month, my cofounder Kristy Hawkins and I presented at SynBioBeta 2020, the flagship conference for the synthetic biology community. This year’s virtual event...
Blog Posts
As a part of our new “Meet the Team” series, we hear from Ken Takeoka, Antheia’s very first employee and a Scientist III. Read on...
Blog Posts
It’s a momentous day for my research team at Stanford University. Today, we’ve announced a new paper published in Nature that describes the first successful...
Blog Posts
Over the last 150 years, the pharmaceutical industry has focused on decoupling the production of medicinal compounds from their sources in the natural world, which...
Blog Posts
We started Antheia four years ago with a steadfast commitment to help build a more robust drug supply chain – one that delivers the right...
Blog Posts
mericans spend over $300 billion on pharmaceutical drugs every year. In normal times, the supply chain behind these drugs is designed to go unnoticed......